Moximed (Series D)
Funding Details
Awarder
Inbox
Date Award
August 13, 2024
Vertical
Med-Tech
Funding Amount
$91,000,000
Company Info
Market
Knee Osteoarthritis Treatment
Location
Fremont, California, USA
Coinvestors
Advent Life Sciences, Cormorant Asset Management, Elevage Medical Technologies, Future Fund, GBS Venture Partners, Gilde Healthcare Partners, Morgenthaler, New Enterprise Associates, Vertex Ventures, Warren Point Capital
Company Description

Moximed develops innovative therapies for patients with knee osteoarthritis.